Observational Study of Exposure to Environmental Toxicants Among Firefighters

Sponsor
Masonic Cancer Center, University of Minnesota (Other)
Overall Status
Recruiting
CT.gov ID
NCT05643014
Collaborator
(none)
60
1
46.9
1.3

Study Details

Study Description

Brief Summary

Observational, within subject study design with 1 pre and 2 post-fire exposure biomarker samples collected to assess exposure to toxicants from combustion emissions related to fighting a structural fire.

Condition or Disease Intervention/Treatment Phase
  • Other: Sample collection

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Evaluate the Exposure to Toxicants Emitted During a Structural Fire Assessed by Urinary and Buccal Cell Biomarkers Found in Firefighters.
Actual Study Start Date :
Feb 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Firefighters over 18 years old

This is a within subject, observational study of firefighters. This study will involve three sample collections including buccal cells and urine samples; one collection pre and two collections post-structural fire exposure.

Other: Sample collection
This study will involve three sample collections including buccal cells and urine samples

Outcome Measures

Primary Outcome Measures

  1. Studying biomarker levels in firefighters pre and post fire call. [48 months]

    The investigators will evaluate the differences between mean pre-exposure biomarker levels and post-exposure levels in urine and buccal samples collected within 24 hours post-exposure and 1-week post-exposure respectively using t-tests to test for statistical significance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Firefighter (career or volunteer)

  • Over 18 years of age

  • Able to provide written voluntary consent

Exclusion Criteria:
  • Unwilling to provide a pre and post-exposure urine sample

  • Current cancer diagnosis

  • Tobacco use within the last 1 year (verified by urinary TNEs)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Masonic Cancer Center Minneapolis Minnesota United States 55455

Sponsors and Collaborators

  • Masonic Cancer Center, University of Minnesota

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Masonic Cancer Center, University of Minnesota
ClinicalTrials.gov Identifier:
NCT05643014
Other Study ID Numbers:
  • 2018NTLS135
First Posted:
Dec 8, 2022
Last Update Posted:
Dec 15, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Masonic Cancer Center, University of Minnesota

Study Results

No Results Posted as of Dec 15, 2022